Tekla Life Sciences Investors

NYSE:HQL

Asset Management

Financial Services
$19.27 +0.62%

+$0.11 today

Market cap
$585.96M
Beta
0.73
P/E (TTM)
2.8
EPS (TTM)
$6.52
Dividend yield
11.35%
52W Low $12.34High $18.46

Volume 0.12M

Average 0.11M

HQL Operating Cash Flow

Cash generated by the company's core business operations during the period.

Tekla Life Sciences InvestorsNYSE: HQL

Operating Cash Flow · Q2 FY2026 · quarter ended Mar 2026

Operating cash flow grows 16.7% year over year

Q2 FY2026 operating cash flow of $1.22M (cash outflow) rose 16.7% year over year.

Context

  • Operating cash flow amounted to 2.7% of revenue in FY2025.
  • Operating cash flow increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.22M— QoQ
Last fiscal yearSep 2025
-$2.32M— YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.7%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
(2.32M) USD
Year-over-year change
—

Operating Cash Flow vs competitors

How HQL compares with its peers on the latest reported figures

  • HQL's FY2025 operating cash flow of $2.32M is the 9th largest of the 10 companies compared; the peer median is $66.05M.
  • Operating cash flow amounts to 2.7% of revenue for HQL, versus a peer median of 51.0%.
HQL Competitors Peer median
Operating Cash Flow for HQL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PNNTPennantPark Investment CorporationLTM Mar 2026$161.13M +15.4%—195.8%
TCPCBlackRock TCP Capital Corp.LTM Mar 2026$144.69M -53.7%-8.8%591.8%
CIONCION Investment CorporationLTM Mar 2026$75.4M +639.9%+29.6%51.0%
ECCEagle Point Credit Company Inc.LTM Dec 2025$71.1M -31.3%-34.1%42.4%
CCAPCrescent Capital BDC, Inc.LTM Mar 2026$66.05M +110.0%+8.6%52.9%
GLADGladstone Capital CorporationLTM Mar 2026$53.56M -144.9%—75.9%
GAINGladstone Investment CorporationLTM Mar 2026$26.46M -77.8%+182.6%23.6%
MCIBarings Corporate InvestorsLTM Jun 2025$12.73M -63.0%+68.0%31.0%
HQLTekla Life Sciences InvestorsFY2025$2.32M ——2.7%
SORSource Capital, Inc.FY2024$0 ——0.0%
Peer median (excluding HQL) $66.05M-42.5%+19.1%51.0%

Competitors are the stored peer set for HQL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2020
Sep 2020
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2025
Sep 2025
Net Income123.05K64.53K(104.6K)22.35M85.59M
Depreciation & Amortization00000
Deferred Income Tax00000
Stock-Based Compensation00000
Change in Working Capital0000(203.41K)
Accounts Receivables000059.23K
Inventory00000
Accounts Payables00000
Other Working Capital0000(262.64K)
Other Non-Cash Items(123.05K)(64.53K)104.6K(22.35M)(87.71M)
Operating Cash Flow0000(2.32M)
Capital Expenditures0000(5)
Acquisitions (Net)00000
Purchases of Investments0000(314.13M)
Sales of Investments0000339.34M
Other Investing Activities00000
Investing Cash Flow000025.21M
Debt Repayment00000
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid0000(31.63M)
Other Financing Activities00000
Financing Cash Flow0000(31.63M)
Effect of Forex Changes00008.81M
Net Change in Cash0990(545)3275.54K
Free Cash Flow0000(2.32M)

Tekla Life Sciences Investors

NYSE:HQL

Intrinsic Alpha fair value

Locked

Current Price

$19.27

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.